Boehringer Ingelheim To Acquire Actimis Pharmaceuticals

Boehringer Ingelheim GmbH announced an agreement to acquire Actimis Pharmaceuticals, Inc., a privately owned biotech company based in San Diego. The acquisition will occur through a structured buyout in which Boehringer Ingelheim will acquire shares of Actimis depending on the achievement of several successive milestones with Actimis' leading asthma compound AP768. ...

Write comment to this article:

Subject:

Name:

email or site:

Code: